bpc 157 research chemical BPC-157 and other peptides are everywhere in the fitness world right now. The anecdotal reports (and some early research) are exciting! But, we still need to approach BPC-157 with caution. Right now BPC-157 Peptide (Research, ≥98% Purity)

The FDA enforcement-discretion period that allowed mass compounding during the tirzepatide shortage ended on March 19, 2025 for 503B outsourcing facilities and February 18, 2025 for 503A pharmacies

One concentration-math example uses 7.5 mL of bacteriostatic water for a 750 mg vial, giving 100 mg/mL

Koi Peptides is a chemical research supplier not a compounding pharmacy or outsourcing facility under sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act and supplies no compounded preparations of any kind

PMID: 3776352

Sculptra is effective and safe and recommended to 89% of our patients

PLoS One 7:e40365